High-performance chromatographic assay for the sulphoxide metabolite 2'-deoxy-3'-thiacytidine in human urine

Journal of Chromatography B: Biomedical Applications

Volumn 687, Issue 2, 1996, Pages 457-461

  Plumb, R S ^a   Gray, R D M ^a   Harker, A J ^a   Taylor, S ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

2' Deoxy 3' thiacytidine; Lamivudine

Indexed keywords

DRUG METABOLITE; GI 138870X; LAMIVUDINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; TECHNIQUE; ULTRAVIOLET SPECTROPHOTOMETRY;

ANTI-HIV AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIC S-OXIDES; HUMANS; LAMIVUDINE;

EID: 0030582628     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(96)00247-2     Document Type: Article

References (5)

1. [1] J.A.V. Coates, N. Cammack, H.J. Jenkinson, A.J. Jowett, M.I. Jowett, B.A. Pearson, C.R. Penn, P.L. Rouse, K.C. Viner and J.M. Cameron, Antimicrob. Agents Chemother., 36 (1992) 733.
2. [2] Glaxo Research and Development Expert Report on the Preclinical Documentation of Lamivudine.
3. [3] A.J. Harker, G.L. Evans, A.E. Hawley and D.M. Morris, J. Chromatogr. B, 657 (1994) 227-232.
4. [4] D.F. Hagen, G.G. Markell and G.S. Schmitt, Anal. Chim. Acta, 236 (1990) 157-164.
5. [5] G.C. Mattern, J.B. Louis and J.D. Rosen, J. Assoc. Off. Anal. Chem., 74 (1991) 982.